Q. What has DSV has been doing to develop its pharma logistics network generally, before and aſter the virus? How will it take things forward once the Covid crisis is finally over? A. “With the finalized Panalpina integration,

DSV Panalpina’s

capabilities within pharma and healthcare have been further strengthened and we can now play on the strengths of both the former Panalpina and DSV business within this sector. Through our PharmaQMS initiative, we have developed our global network to 110 compliant

locations with

another 90+ locations being added this year. We have educated around 3,400 employees who support our pharma and healthcare customers daily. The magnitude of the Covid-19

FBJ talked in late March to Andreas Sahli, vice-president, global vertical lead, healthcare, DSV Panalpina. everything

pandemic has, of course, brought more attention to pharma. That said - Covid-19 or no Covid-19 - pharma and healthcare has been a focus area for DSV Panalpina all along. The plan is to continue to improve this segment of our business even more.”

Are other types of pharma traffic continuing to develop, besides the Covid vaccine? “The pharma and healthcare industry is growing, and the ageing of the world’s population, lifestyle diseases and precision medicine will increase the demand for more and different products. We are growing our global cold chain and pharma capabilities to accommodate this demand and to be able to adjust to new requirements when transporting

Issue 3 2021 - Freight Business Journal

More technologically advanced supply chains of, for instance, biotechnical products will require even higher standards to cold chain logistics as well as in tracking and tracing of these shipments. We are constantly reviewing and improving our framework, so we are ready to accommodate these expectations in the future.”

from temperature-

sensitive products to OTC- products. Currently, we are supporting

pharma and healthcare companies globally in many sub-segments like chemical-based products, cancer treatments, biotech, veterinary and medical devices. Throughout the whole Covid-19 crisis, it has been important for us not to weaken our focus on all the other pharma and healthcare products, which are also highly crucial to get to hospitals and patients.”

What are the long-term prospects for pharma traffic? “We expect a steady growth in the pharma and healthcare industry, and we are ready and capable to support the industry with a first- class supply chain offering as well.

Delta supports global pandemic-beating efforts US airline Delta continues to

support the global effort to beat the pandemic with numerous successful Covid-19 vaccine shipments within the US. The critical vaccines are shipped with the highest priority in the belly of the Delta aircraſt, with the entire journey monitored by Delta’s Vaccine Watch Tower that enables full end-to-end visibility for all shipments. With 24/7 centralized monitoring

and customer

reporting, the Tower works closely with Flight Operations to ensure the safe and secure transportation of the vaccines at the required temperature. The Vaccine Watch Tower,

open 24/7, enables end-to-end visibility for all shipments with centralized monitoring and customer reporting. The team follows each consignment from booking to delivery, proactively updating customers every step of the way. If there is disruption during any part of the journey, it works across divisions on a recovery plan to ensure the vaccines reach final destination. The Vaccine Task Force, created

last summer to understand shipping

requirements and work with healthcare and pharmaceutical experts, has

built scalable critical shipment capabilities to support this effort. By working closely with industry and Government stakeholders as well as healthcare companies and freight forwarders, Delta was able to discuss its capabilities and

IATA’s Center of Excellence for Independent Validators Pharma Logistics Certification (CEIV) at its Atlanta hub and headquarters. Even before the Covid-19 pandemic, Delta offered four tailored pharmaceutical shipping options which meet specific

Has the world lost sight of the fact that there are many other illnesses that affect people, especially in the developing world, and we still need to get medicines to them? “Of course, due to the Covid-19 pandemic, there is a tremendous public focus on distributing Covid-19 vaccines. That’s understandable.

25 the transportation of goods.”

What role does the DSV air charter network play for pharma logistics and will you continue to develop it, especially if scheduled air capacity remains tight? “The DSV air charter network is an important asset for us to make sure DSV always has a robust pharma and healthcare logistics set-up – even in the midst of a crisis. As an example, we were able to secure important airfreight capacity for our customers during the first wave of the Covid-19 pandemic and

we But in my

experience from our day-to-day dialogue with our customers, the pandemic has not stopped the companies from continuing their research and development to fight other diseases and illnesses and neither have we as transport and logistics professionals delivering these other products. “Recently, I spoke to a senior manager in a pharma company,

domestic shipment capabilities it has “a broad and nimble” global distribution network in coordination with airline partners that provide worldwide reach with stop-gap reliability and greater ability to warehouse and ship vaccines from more global hubs. Delta Cargo launched a Cargo Charter operation

in March

2020 to provide safe and reliable transportation of goods around the globe by working primarily with

the airline’s established

logistics partners, dispatching idled aircraſt on cargo-only flights to transport millions of pounds of supplies. It has now operated over 2,500 flights and is now averaging 15 globally each week, carrying medical and PPE equipment, pharmaceuticals, US mail, home office supplies and food. But it adds that this is not new;

the network, as well as learn about the different transportation needs of the different vaccines. Regular executive level, personalized contact with the key stakeholders was critical, it says. It adds that its extensive

experience in shipping vaccines involves years of building an operation

validated against

pharma industry standards including becoming the first US passenger airline to receive

temperature requirements for

vaccines ensuring integrity through the entire journey. With large warehouses and

cooler facilities in Atlanta, Detroit, Los Angeles, New York-JFK and Seattle, plus pharma facilities at 75 other domestic airports and a network of 49 certified pharma airports across the globe, Delta says it has the infrastructure to support Covid-19 vaccine shipments. In addition to its

Delta and many airlines have extensive experience shipping of vaccines and Delta. But certainly, the logistical challenge of the sheer scale/volume of the distribution of the Covid-19 vaccine around the globe as well as the stakeholder complexity requires its teams to be nimble and flexible. This is also made more challenging as the different vaccines have different requirements for transportation with Pfizer vaccines being outside of normal temp range with their own packaging.

and he thanked DSV Panalpina for continuing to have a strong focus on other pharma products and, I am certain, he is not the only one.”

Has the Covid crisis made it harder to operate other aspects of the pharma supply chain? “The lack of airfreight capacity combined with congestion in

seaports has been a major

challenge to the market. And these dynamics have been caused by the Covid-19 pandemic. But I don’t think the pharma supply chain has been significantly more challenged compared to the rest of the market. The lack of airfreight capacity constitutes a universal problem for

have continuously

expanded our network with new destinations to make sure we can handle new challenging situations and support our customers’ needs. Our airfreight-hubs in Luxembourg and Huntsville, Alabama are state of the art pharma and healthcare locations with a very short tarmac time, pharma graded cross-dock terminals and, of course, certified according to our PharmaQMS framework. “Our Air Charter and dedicated

pharma and healthcare teams will continue to assess how to expand to the benefit of our customers. Recently, we added cities like Johannesburg, Shanghai, Rio de Janeiro to our charter network and my best guess is that more will follow.”

Airfreight industry teams up to move the vaccine

The 12-member SkyTeam Cargo global airline alliance has launched V Excellence, a dedicated program for shipping Covid-19 vaccines as immunisation programmes roll out worldwide. It covers the transport of

Covid-19 vaccine shipments moved under its members’ Customized Vaccines product family, offering special handling, priority handling. Most members hold IATA Centre of Excellence for Independent Validators (CEIV) certification and are experts in the transportation of pharmaceutical, health care and life science products, including procedures for dry ice to maintain ultra-cold temperatures. SkyTeam Cargo chairman

and chief executive of Saudia Cargo, Omar Hariri, said: “V Excellence is backed by a vast network reach combined with years of experience in special

handling to guarantee the

safe, reliable transportation of millions of doses of COVID-19 vaccines between continents. Vaccines are vital to tackling the pandemic and as production ramps up, SkyTeam Cargo members have the skills and capacity to deliver, facilitating wider access for populations across the globe thanks to our strong partnerships with major freight forwarder experts in the pharma industry.” Senior vice president and head

of the cargo business division at Korean Air, JD Eum, commented: “Korean Air is currently transporting Covid-19 vaccines and related medical supplies to/ from Korea, and will continue to invest all necessary resources to ensure the safe transport of the vaccine. We hope to expand the vaccine’s delivery to more regions by cooperating closely with SkyTeam Cargo members and sharing networks.”

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28